OLK:NSD-Olink Holding AB ADR (USD)

COMMON STOCK | Diagnostics & Research |

Last Closing

USD 23.01

Change

-0.01 (-0.04)%

Market Cap

USD 2.72B

Volume

0.23M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-03 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
IDXX IDEXX Laboratories Inc

+2.51 (+0.46%)

USD 43.04B
ICLR ICON PLC

-1.11 (-0.35%)

USD 26.09B
ILMN Illumina Inc

-3.39 (-2.96%)

USD 18.41B
NTRA Natera Inc

-2.04 (-1.88%)

USD 12.93B
MEDP Medpace Holdings Inc

+0.02 (+0.01%)

USD 12.09B
EXAS EXACT Sciences Corporation

-1.57 (-3.02%)

USD 9.96B
RDNT RadNet Inc

-0.13 (-0.23%)

USD 4.19B
SHC Sotera Health Co

-0.12 (-1.05%)

USD 3.13B
GH Guardant Health Inc

-0.88 (-3.35%)

USD 2.74B
NEOG Neogen Corporation

+0.13 (+0.97%)

USD 2.67B

ETFs Containing OLK

EVNT AltShares Event-Driven ET.. 4.07 % 0.00 %

-0.04 (-0.37%)

USD 4.51M

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -8.51% 63% D 37% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -8.51% 63% D 37% F
Trailing 12 Months  
Capital Gain 4.02% 76% C+ 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.02% 75% C 51% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 0.86% 51% F 48% F
Dividend Return 0.86% 49% F 44% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 35.33% 80% B- 52% F
Risk Adjusted Return 2.42% 51% F 42% F
Market Capitalization 2.72B 84% B 83% B

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector